Brio Consultants’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Sell |
863
-436
| -34% | -$105K | 0.03% | 126 |
|
|
2025
Q1 | $316K | Sell |
1,299
-440
| -25% | -$107K | 0.05% | 93 |
|
|
2024
Q4 | $571K | Sell |
1,739
-434
| -20% | -$143K | 0.09% | 75 |
|
|
2024
Q3 | $727K | Sell |
2,173
-433
| -17% | -$145K | 0.12% | 67 |
|
|
2024
Q2 | $712K | Buy |
2,606
+4
| +0.2% | +$1.09K | 0.12% | 64 |
|
|
2024
Q1 | $900K | Hold |
2,602
| – | – | 0.15% | 61 |
|
|
2023
Q4 | $840K | Buy |
+2,602
| New | +$840K | 0.15% | 61 |
|
|
2021
Q4 | – | Sell |
-375
| Closed | -$280K | – | 71 |
|
|
2021
Q3 | $280K | Sell |
375
-20
| -5% | -$14.9K | 0.07% | 68 |
|
|
2021
Q2 | $254K | Sell |
395
-9
| -2% | -$5.79K | 0.06% | 71 |
|
|
2021
Q1 | $231K | Sell |
404
-18
| -4% | -$10.3K | 0.07% | 68 |
|
|
2020
Q4 | $246K | Buy |
+422
| New | +$246K | 0.08% | 66 |
|